[go: up one dir, main page]

NZ187050A - Optically active 6,6 dimethylnrpinenes - Google Patents

Optically active 6,6 dimethylnrpinenes

Info

Publication number
NZ187050A
NZ187050A NZ187050A NZ18705077A NZ187050A NZ 187050 A NZ187050 A NZ 187050A NZ 187050 A NZ187050 A NZ 187050A NZ 18705077 A NZ18705077 A NZ 18705077A NZ 187050 A NZ187050 A NZ 187050A
Authority
NZ
New Zealand
Prior art keywords
dimethylnrpinenes
optically active
optically
active
Prior art date
Application number
NZ187050A
Inventor
Wa Day
Ra Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/740,502 external-priority patent/US4102902A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ187050A publication Critical patent/NZ187050A/en

Links

NZ187050A 1976-11-10 1977-06-30 Optically active 6,6 dimethylnrpinenes NZ187050A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/740,502 US4102902A (en) 1976-11-10 1976-11-10 Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor
NZ184526A NZ184526A (en) 1976-11-10 1977-06-30 Preparation of an optical isomer of 1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyron-9-ones

Publications (1)

Publication Number Publication Date
NZ187050A true NZ187050A (en) 1979-03-16

Family

ID=26649746

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ187050A NZ187050A (en) 1976-11-10 1977-06-30 Optically active 6,6 dimethylnrpinenes

Country Status (1)

Country Link
NZ (1) NZ187050A (en)

Similar Documents

Publication Publication Date Title
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
ZA776900B (en) N,n'-methylenebis-(o,o-diaryl n-phosphono-methylglycinonitriles)
GB1524917A (en) Gona-1,9(10)-dienes
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
PH17398A (en) 1,5-disubstituted-2-pyrrolidones
PH15708A (en) 2,6-methanol-2h-1-benzoxocins
AU511513B2 (en) Optically active anthracylinones
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU500386B2 (en) 1,2,6-thidiazinones
IL52152A (en) 3,5,5-trimethylhexonoyl ferrocene
AU2468877A (en) 1,4 -dicyanobytene
AU505974B2 (en) 3', 4'-dideoxykanamcin b
GB1534997A (en) O-ethyl-s-n-propyl-0,2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
GB1537635A (en) 15,16-dihydroxyprostaglandins
GB1544878A (en) Optically active alkoxycyproheptadines
AU3191777A (en) 1,4-oxathianes
NZ187050A (en) Optically active 6,6 dimethylnrpinenes
AU514741B2 (en) 5,6-dehydropenicillins
KE3185A (en) 2,3 dihydro-2-oxo-3-benzo (b) thiophene-carboxamides
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
GB1554045A (en) 13,14-didehydroprostaglandins
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
AU524600B2 (en) 2,6-methano-3-benzazocines
PL187440A1 (en) Sposob wytwarzania nowych pochodnych 3,4-dwuhydro-2h-1,3-benzoksazynotionu-2